S 373 117th Congress Senate Health Drug safety, medical device, and laboratory regulation Health information and medical records Product development and innovation

BENEFIT Act of 2021

Introduced: February 23, 2021 Introduced by: Wicker, Roger F. Republican · Mississippi See on congress.gov

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Feb 23, 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Feb 23, 2021

Introduced in Senate

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Plain-English summary Congressional Research Service

Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2021 or the BENEFIT Act of 2021

This bill requires the Food and Drug Administration (FDA) to consider relevant patient-focused drug development data, such as data from patient preference studies and patient-reported outcome data, in the risk-benefit assessment framework used in the process for approving new drugs.

After a new drug application has been approved, the FDA's public statement about how it used patient experience data shall include a description of how such data was considered in the risk-benefit assessment framework.

What's happening now February 23, 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Related & companion bills 1

Bill text 1 version